Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-05-12 @ 10:08 PM
Study NCT ID:
NCT05994157
Status:
RECRUITING
Last Update Posted:
2025-01-29
First Post:
2023-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
Y-mAbs Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None